Complementary roles of antibody affinity and specificity for in vivo diagnostic cardiovascular targeting: How specific is antimyosin for irreversible myocardial damage?

Journal of Nuclear Cardiology

Volumn 6, Issue 3, 1999, Pages 316-323

  Khaw, Ban An ^a,b   Petrov, Artiom ^a,c   Narula, Jagat ^a,b,c  

^a NORTHEASTERN UNIVERSITY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c Allegheny University   (United States)

Author keywords

Affinity; Antimyosin antibody; Gamma imaging; Specificity

Indexed keywords

MYOSIN ANTIBODY; THALLIUM 201;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; ARTICLE; AUTOPSY; CONTROLLED STUDY; DOG; GAMMA RADIATION; HEART MUSCLE INJURY; HISTOCHEMISTRY; ISOTOPE LABELING; NONHUMAN; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

EID: 0032981338     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-3581(99)90044-2     Document Type: Article

References (26)

1. Khaw BA, Fallon JT, Beller GA, Haber E. Specificity of localization of myosin specific antibody fragments in experimental myocardial infarction: histologic, histochemical, autoradiographic and scintigraphic studies. Circulation 1979;60:1527-31.
2. Khaw BA, Beller GA, Haber E. Experimental myocardial infarct imaging following intravenous administration of Iodine-131 labeled antibody (Fab')2 fragments specific for cardiac myosin. Circulation 1978;57:743-50.
3. Khaw BA, Gold HK, Yasuda T, et al. Scintigraphic quantification of myocardial necrosis in patients after intravenous injection of myosin specific antibody. Circulation 1986;74:501-8.
4. Khaw BA, Yasuda T, Gold HK, et al. Acute myocardial infarct imaging with Indium-111-labeled monoclonal antimyosin Fab. J Nucl Med 1987;28:1671-8.
5. Johnson LL, Seldin DW, Becker LC, et al. Antimyosin imaging in acute transmural myocardial infarction: results of a multicenter clinical trial. J Am Coll Cardiol 1989;13:27-35.
6. Jain D, Lahiri A, Rafferty E. Immunoscintigraphy for detecting acute myocardial infarction without electrocardiographic changes. BMJ 1990;300:151-3.
7. Berger H, Lahiri A, Leppo J, et al. Antimyosin imaging in patients with ischemic chest pain: initial results of Phase III Multicenter Trial [Abstract]. J Nucl Med 1988;28:805.
8. Yasuda T, Palacios IF, Dec GW, et al. Indium-111 monoclonal antimyosin antibody imaging in the diagnosis of acute myocarditis. Circulation 1987;76:306-11.
9. Dec GW, Palacios I, Yasuda T, et al. Antimyosin antibody cardiac imaging: its role in the diagnosis of myocarditis. J Am Coll Cardiol 1990;16(1):97-104.
10. Narula J, Southern JF, Abraham S, Pieri P, Khaw BA. Myocarditis simulating myocardial infarction. Clinicopathologic Conferences. J Nucl Med 1991;32:312-8.
11. Khaw BA, Nakazawa A, O'Donnell SM, Pak KY, Narula J. Avidity of 99m glucarate for the necrotic myocardium: in vivo and in vitro assessment. J Nucl Cardiol 1997;4:283-90.
12. Khaw BA, Mattis JA, Melincoff G, Strauss HW, Gold HK, Haber E. Monoclonal antibody to cardiac myosin: scintigraphic imaging of experimental myocardial infarction. Hybridoma 1984;3:11-23.
13. Porter RR. The hydrolysis of rabbit γ-globulin and antibodies with crystalline papain. Biochem J 1959;73:119-26.
14. Krejcarek GE, Tucker KL. Covalent attachment of chelating groups to macromolecules. Biochem Biophys Res Comm 1977;77:581-5.
15. Khaw BA, Fallon JT, Strauss HW, Haber E. Myocardial infarct imaging with Indium-111-diethylene triamine pentaacetic acid-anticanine cardiac myosin antibodies. Science 1980;209:295-7.
16. Marchalonis JJ. An enzymatic method for the trace iodination of immunoglobulins and other proteins. Biochem J 1969;113:299-305.
17. Khaw BA, Beller GA, Haber E, Smith TW. Localization of cardiac myosinspecific antibody in myocardial infarction. J Clin Invest 1976;58:439-46.
18. Khaw BA, Cooney J, Edgington T, Strauss HW. Differences in experimental tumor localization of dual-labeled monoclonal antibody. J Nucl Med 1986;27:1293-9.
19. Student T Test from the statistical package in Borland Quattro Pro, Version 5 for Windows. Copyright 1987 and 1993. Borland International, Inc, Scotts Valley, Calif.
20. Fischman AJ, Khaw BA, Strauss HW. Quo vadis: radioimmune imaging. J Nucl Med 1989;30:1911-3.
21. Khaw BA. Antibodies: considerations for in vitro and in vivo application. In: Monoclonal antibodies in cardiovascular diseases. Khaw BA, Narula J, Strauss HW, editors. Philadelphia: Lea & Febiger; 1994. p. 4-5.
22. Khaw BA, Fallon JT, Beller GA, Haber E. Specificity of localization of myosin specific antibody fragments in experimental myocardial infarction: histologic, histochemical, autoradiographic and scintigraphic studies. Circulation 1979;60:1527-31.
23. 2. J Appl Cardiol 1987;2:185-211.
24. Khaw BA, Gansow O, Brechbiel MW, Nossiff ND. Use of isothiocyanatobenzyl DTPA derivatized monoclonal antimyosin Fab for enhanced in vivo target localization. J Nucl Med 1990;31:211-7.
25. Khaw BA, Klibanov A, O'Donnell SM, et al. Gamma imaging with negatively charge-modified monoclonal antibody: modification with synthetic polymers. J Nucl Med 1991;32:1742-51.
26. Khaw BA, Strauss HW, Narula J. "Magic bullets": from muskets to smart bombs!!! Review article. J Nucl Med 1993;34:2264-8.